Abiomed, Inc.ABMDNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P15
Within normal range
vs 2Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2022 | -0.88% |
| Q2 2022 | 7.66% |
| Q1 2022 | 1.85% |
| Q4 2021 | 4.71% |
| Q3 2021 | -0.68% |
| Q2 2021 | 3.10% |
| Q1 2021 | 16.45% |
| Q4 2020 | 8.88% |
| Q3 2020 | 15.67% |
| Q2 2020 | -18.41% |
| Q1 2020 | -2.08% |
| Q4 2019 | -0.33% |
| Q3 2019 | -0.14% |
| Q2 2019 | 5.88% |
| Q1 2019 | 1.34% |
| Q4 2018 | 1.68% |
| Q3 2018 | -2.77% |
| Q2 2018 | 7.47% |
| Q1 2018 | 13.44% |
| Q4 2017 | 10.78% |
| Q3 2017 | -0.85% |
| Q2 2017 | 0.83% |
| Q1 2017 | 11.43% |
| Q4 2016 | 1.60% |
| Q3 2016 | 4.02% |
| Q2 2016 | 12.76% |
| Q1 2016 | 8.13% |
| Q4 2015 | 5.08% |
| Q3 2015 | 6.71% |
| Q2 2015 | 8.07% |
| Q1 2015 | 14.59% |
| Q4 2014 | 2.32% |
| Q3 2014 | -6.78% |
| Q2 2014 | 10.02% |
| Q1 2014 | 17.88% |
| Q4 2013 | -7.00% |
| Q3 2013 | -6.32% |
| Q2 2013 | 17.05% |
| Q1 2013 | 14.09% |
| Q4 2012 | 13.59% |